Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational Materials

Susan Chimonas; Carol Cosenza; Aaron S. Kesselheim; Gita A. Toyserkani; Kate Heinrich Oswell; Cynthia LaCivita; Gerald J. Dal Pan; Ameet Sarpatwari

doi:10.1007/s40264-025-01636-4

Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational Materials

Susan Chimonas
, Carol Cosenza
, Aaron S. Kesselheim
, Gita A. Toyserkani
, Kate Heinrich Oswell
, Cynthia LaCivita
, Gerald J. Dal Pan
, Ameet Sarpatwari

Ctr for Survey Research

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Drug Safety
DOIs	https://doi.org/10.1007/s40264-025-01636-4
State	Accepted/In press - 2025

ASJC Scopus Subject Areas

Toxicology
Pharmacology
Pharmacology (medical)

Access to Document

10.1007/s40264-025-01636-4

Cite this

@article{7e50ffc8607849cdbcb89818abf4beb7,

title = "Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational Materials",

author = "Susan Chimonas and Carol Cosenza and Kesselheim, \{Aaron S.\} and Toyserkani, \{Gita A.\} and Oswell, \{Kate Heinrich\} and Cynthia LaCivita and \{Dal Pan\}, \{Gerald J.\} and Ameet Sarpatwari",

note = "Publisher Copyright: {\textcopyright} The Author(s), under exclusive licence to Springer Nature Switzerland AG 2025.",

year = "2025",

doi = "10.1007/s40264-025-01636-4",

language = "English",

journal = "Drug Safety",

issn = "0114-5916",

publisher = "Adis",

}

TY - JOUR

T1 - Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy

T2 - Patient Perspectives on Risk Communication and the Value of Educational Materials

AU - Chimonas, Susan

AU - Cosenza, Carol

AU - Kesselheim, Aaron S.

AU - Toyserkani, Gita A.

AU - Oswell, Kate Heinrich

AU - LaCivita, Cynthia

AU - Dal Pan, Gerald J.

AU - Sarpatwari, Ameet

PY - 2025

Y1 - 2025

UR - https://www.scopus.com/pages/publications/105023068691

UR - https://www.scopus.com/pages/publications/105023068691#tab=citedBy

U2 - 10.1007/s40264-025-01636-4

DO - 10.1007/s40264-025-01636-4

M3 - Article

C2 - 41307831

AN - SCOPUS:105023068691

SN - 0114-5916

JO - Drug Safety

JF - Drug Safety

ER -

Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational Materials

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this